Reducing violence risk in persons with schizophrenia: olanzapine versus risperidone

Area of Science:

• Psychiatry and Mental Health
• Pharmacological Interventions
• Clinical Research

Background:

• Schizophrenia is a complex mental disorder often associated with violent behavior.
• Antipsychotic medications like olanzapine and risperidone are commonly used in managing schizophrenia.
• Understanding the comparative effectiveness of these treatments in real-world settings is crucial.

Purpose of the Study:

• To prospectively compare the effectiveness of olanzapine versus risperidone in reducing violent behavior among community-dwelling patients with schizophrenia.
• To investigate the impact of long-term treatment with these antipsychotics on violence risk.

Main Methods:

• An observational study followed 124 adults with schizophrenia for 3 years.
• Data on treatment, clinical outcomes, and violent behavior were collected through 6-month interviews.
• Multivariable time-series analysis was used to compare violence rates.

Main Results:

• Long-term olanzapine treatment (≥1 year) significantly reduced violence risk compared to initial treatment periods.
• No significant change in violence risk was observed with long-term risperidone treatment.
• Improved medication adherence mediated the reduction in violent behavior associated with olanzapine.

Conclusions:

• In real-world settings, long-term olanzapine treatment offers an advantage over risperidone in reducing violence risk for patients with schizophrenia.
• This benefit is partly attributed to improved treatment adherence with olanzapine.
• Medication adherence is a key factor in the effectiveness of antipsychotic treatment for reducing violence in schizophrenia.